NASDAQ · SI
Healthcare · Medical - Specialties
$18.07
Down-$0.07 (-0.36%)
Updated Oct 14, 2026, 4:05 PM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · SI
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 13, 2026
SI closed at $18.07 after 21 trading sessions, up 0.67% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 13, 2026 | $18.25 | $18.95 | $17.955 | $18.07 | 69.13K |
| Oct 12, 2026 | $18.30 | $18.40 | $17.97 | $18.23 | 69.15K |
| Oct 9, 2026 | $17.75 | $18.635 | $17.75 | $18.13 | 90.99K |
| Oct 8, 2026 | $18.70 | $19.015 | $17.795 | $17.89 | 100.91K |
| Oct 7, 2026 | $19.27 | $19.325 | $18.495 | $18.71 | 81.76K |
| Oct 6, 2026 | $19.56 | $19.91 | $19.03 | $19.14 | 126.98K |
| Oct 5, 2026 | $18.81 | $20.03 | $18.74 | $19.60 | 148.09K |
| Oct 2, 2026 | $18.89 | $19.4899 | $18.545 | $19.01 | 144.35K |
| Oct 1, 2026 | $18.90 | $19.60 | $18.455 | $18.75 | 213.36K |
| Sep 30, 2026 | $18.84 | $19.50 | $18.44 | $18.90 | 191.19K |
| Sep 29, 2026 | $17.80 | $18.99 | $17.78 | $18.79 | 162.24K |
| Sep 28, 2026 | $16.95 | $18.3174 | $16.56 | $17.95 | 155.21K |
| Sep 25, 2026 | $17.08 | $17.43 | $16.81 | $16.99 | 77.09K |
| Sep 24, 2026 | $17.21 | $17.40 | $16.815 | $17.01 | 79.87K |
| Sep 23, 2026 | $17.64 | $18.05 | $17.00 | $17.37 | 97.91K |
| Sep 22, 2026 | $17.44 | $18.17 | $17.255 | $17.61 | 108.09K |
| Sep 21, 2026 | $18.42 | $18.69 | $17.0946 | $17.52 | 61.43K |
| Sep 18, 2026 | $17.78 | $18.66 | $17.625 | $18.16 | 622.09K |
| Sep 17, 2026 | $18.07 | $18.33 | $17.37 | $17.80 | 155.71K |
| Sep 16, 2026 | $17.95 | $18.33 | $17.75 | $17.89 | 84.75K |
| Sep 15, 2026 | $17.78 | $18.28 | $17.58 | $17.95 | 92.34K |
The latest Smart Investors Daily articles mentioning SI.
Company
Market Activity
Research & News
SI research
Company profile and research snapshot.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 12, 2026 | BTIG | Buy | — |
| Aug 10, 2026 | UBS | Buy | — |
| Aug 7, 2026 | Piper Sandler | Overweight | — |
| Aug 7, 2026 | BTIG | Buy | — |
| Jul 28, 2026 | UBS | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Sep 16, 2026
Shoulder Innovations, Inc. (SI) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 3:20 PM EDTCompany ParticipantsRobert Ball -...
Yahoo · Sep 10, 2026
Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the N-22 Humeral Head, a titanium implant option for patients with metal hypersensitivity. Alongside the clearance, the company also announced the product's full commercial launch.
Benzinga · Sep 10, 2026
Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market,
Yahoo · Sep 9, 2026
Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has entered into an exclusive collaboration with ALM Ortho, Inc. ("ALM Ortho"), a leader in additive manufacturing of titanium orthopedic implants, to introduce a bespoke implant for the treatment of severe shoulder deformity and other highly complex revision cases, circumstances f
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SI.
